The evaluation of prognostic value of immunological markers in acute lymphoblastic leukemia (ALL) after intensification of treatment schedule.
In 92 children with acute lymphoblastic leukemia (ALL) immunological markers were evaluated after intensification of the initial treatment. The comparison of the present and previous results showed that with intensification of induction and consolidation therapy, the equally good outcome for T-ALL and non-T, non-B ALL could be achieved. The failure of the therapy in B-disease suggested the need of elaboration of a new strategy for B subset of ALL.